6.30 USD
↘ 0.65 (9.35%)LIVE (AS OF 01:37 PM EDT)
NeuroSense Therapeutics Ltd. Ordinary Shares
NRSNNASDAQ • USD
Market: OPEN
NRSN is currently priced at $6.30. The technical outlook is "Neutral" based on moving average alignment, RSI, and MACD signals. Key drivers include a bearish Death Cross on the long-term moving averages.
Technical & fundamental data as of Sep 11, 2026.
Open?$6.80
High?$7.99
Low?$0.34
Prev. Close?$6.94
Volume?17.9K
Avg. Volume?N/A
VWAP?$6.33
Bid / Ask
Bid?$5.33 × 100
Ask?$7.41 × 100
Spread?$2.08
Midpoint?$6.37
Valuation & Ratios
Market Cap?658.6K
Shares Out?37.9M
Float?24.7M
Float %?65.3%
P/E Ratio?N/A
P/B Ratio?N/A
EPS?N/A
Dividend?N/A
Ex-Dividend?N/A
News
Profile
NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. These diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease, and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.
Technical OutlookNeutral
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-1/3)
Medium-Term (Wave)?▲ Bullish(+1/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental Outlook
Loading...
Short InterestLow
Short % of Float?1.90%Low
Short Interest?469.1K
Days to Cover?1.5
Free Float24.7M
Avg Daily Volume322.0K
Settlement Date2026-08-31